Kun Tong

Sphingomyelin (30:1; O2) as a novel lipid biomarker associated with the diagnosis of intrahepatic cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is a primary hepatic malignancy with an incidence second only to hepatocellular carcinoma (HCC). Preoperative differentiation between ICC and HCC remains challenging in certain cases. This study aimed to identify potential diagnostic lipid bi...